The hepatitis C virus (HCV) is a global disease affecting 170-200 million individuals worldwide. It is also the most common chronic blood borne infection in the United States, affecting 3.2-4.0 million individuals. Unlike other forms of hepatitis that are known for being transmitted sexually, HCV is most commonly transmitted through blood transfusions, needle sticks, and sharing contaminated needles, razors or tattooing instruments. Before 1992, widespread screening of donated blood was not performed. It is estimated that many of today’s cases resulted from past transfusions of donated infected blood. Although the number of new HCV cases in the US has declined due to safer needle practices and improved blood-donor screening, the burden of the disease will continue rising over the next two decades as those already infected with HCV experience disease progression.
- Hep C Search Engine Analysis: How individuals search online for Hepatitis C information and where they go to find it
- Influence of Social Media on the Hep C Market: Understand how social media is impacting the Hepatitis C market
- Current Hep C Treatments and Pipeline Analysis: An analysis of the current Hepatitis C treatments and products currently in the pipeline
- Global/Regional Prevalence of Hep C: This report provides prevalence data for Hepatitis C and the breakdown by genotype
- Introduction and Market Landscape: Why Hep C is so important, what has changed recently
- Analysis Tear Sheet: Outlines the findings from the research and provides recommendations for brand managers and R&D heads on two pages
- Hepatitis C Overview: Disease state overview, prevalence, genotype, treatment guidelines
- Social Media and Search Analysis: How are people searching for Hep C information, where do they go to find information, how does their search progress
- Leading Companies and Products: Profiles the top companies currently providing or planning on providing Hep C treatments
- Hepatitis C Clinical Trial Activity: Analyzes ClinicalTrials.gov data to understand the characteristics of the compounds in development by phase, by sponsor type, by study type across trial length, number of patients, number of studies
- Hepatitis C Market: Provides estimates for the addressable market (e.g. number of patients) by genotype by geographic region
- Recent Industry News: Illustrates the ups and downs of recent Hep C activities
- Glossary of Terms: Provides the reader with a definition of terms used in this report
- Achillion Pharmaceuticals
- Boehringer Ingelheim
- Bristol-Myers Squibb (BMS)
- Gilead Sciences
- Hoffman-La Roche/Genentech
- Idenix Pharmaceuticals
- Johnson & Johnson
- Vertex Pharmaceuticals
ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive
- Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
- Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries. We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
- Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.
For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.